These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 20112799

  • 1. [Outcome of photodynamic therapy for exudative age-related macular degeneration with good visual acuity].
    Tsuchihashi T, Mori K, Yoneya S.
    Nippon Ganka Gakkai Zasshi; 2010 Jan; 114(1):7-13. PubMed ID: 20112799
    [Abstract] [Full Text] [Related]

  • 2. [Assessment of visual acuity in patients with age-related macular degeneration 1 year after photodynamic therapy].
    Tsuzuki K, Honda M.
    Nippon Ganka Gakkai Zasshi; 2010 Jun; 114(6):520-6. PubMed ID: 20593657
    [Abstract] [Full Text] [Related]

  • 3. [Two-year results following photodynamic therapy for age-related macular degeneration].
    Yanagidaira T, Arai J, Yoshida N, Arai S, Fukui E, Imai H, Sugimoto T, Nakamura S, Murata T.
    Nippon Ganka Gakkai Zasshi; 2008 Dec; 112(12):1068-75. PubMed ID: 19157027
    [Abstract] [Full Text] [Related]

  • 4. [Assessment of the quality of life in patients with age-related macular degeneration 1 year after photodynamic therapy].
    Kyo T, Yuzawa M, Tochigi K, Yamaguchi T, Shimozuma K, Fukuhara S, Matsumoto Y.
    Nippon Ganka Gakkai Zasshi; 2007 Apr; 111(4):315-21. PubMed ID: 17461036
    [Abstract] [Full Text] [Related]

  • 5. Intravitreal bevacizumab (Avastin) therapy versus photodynamic therapy plus intravitreal triamcinolone for neovascular age-related macular degeneration: 6-month results of a prospective, randomised, controlled clinical study.
    Weigert G, Michels S, Sacu S, Varga A, Prager F, Geitzenauer W, Schmidt-Erfurth U.
    Br J Ophthalmol; 2008 Mar; 92(3):356-60. PubMed ID: 18303156
    [Abstract] [Full Text] [Related]

  • 6. Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.
    Goff MJ, Johnson RN, McDonald HR, Ai E, Jumper JM, Fu A.
    Retina; 2007 Mar; 27(4):432-8. PubMed ID: 17420694
    [Abstract] [Full Text] [Related]

  • 7. Intravitreal bevacizumab for neovascular age-related macular degeneration with or without prior treatment with photodynamic therapy: one-year results.
    Carneiro AM, Falcão MS, Brandão EM, Falcão-Reis FM.
    Retina; 2010 Jan; 30(1):85-92. PubMed ID: 20010320
    [Abstract] [Full Text] [Related]

  • 8. [Photodynamic therapy in age-related macular degeneration: one-year results].
    Ohira-Tochigi K, Yokoyama E, Matsumoto Y, Kyo T, Yuzawa M.
    Nippon Ganka Gakkai Zasshi; 2008 Oct; 112(10):855-62. PubMed ID: 18949910
    [Abstract] [Full Text] [Related]

  • 9. Association between foveal photoreceptor integrity and visual outcome in neovascular age-related macular degeneration.
    Hayashi H, Yamashiro K, Tsujikawa A, Ota M, Otani A, Yoshimura N.
    Am J Ophthalmol; 2009 Jul; 148(1):83-9.e1. PubMed ID: 19327745
    [Abstract] [Full Text] [Related]

  • 10. Combination of photodynamic therapy and intraocular triamcinolone for exudative age-related macular degeneration and long-term chorioretinal macular atrophy.
    Piermarocchi S, Sartore M, Lo Giudice G, Maritan V, Midena E, Segato T.
    Arch Ophthalmol; 2008 Oct; 126(10):1367-74. PubMed ID: 18852414
    [Abstract] [Full Text] [Related]

  • 11. One-year outcomes of less frequent bevacizumab in age-related macular degeneration.
    Sonmez K, Sonmez PA, Ozkan SS, Atmaca LS.
    Retina; 2011 Apr; 31(4):645-53. PubMed ID: 21358363
    [Abstract] [Full Text] [Related]

  • 12. Bilateral intravitreal bevacizumab injection for exudative age-related macular degeneration: effect of baseline visual acuity.
    Jonas JB, Tao Y, Rensch F.
    J Ocul Pharmacol Ther; 2011 Aug; 27(4):401-5. PubMed ID: 21810019
    [Abstract] [Full Text] [Related]

  • 13. One-year follow-up of combined customized therapy. Photodynamic therapy and bevacizumab for exudative age-related macular degeneration.
    Navea A, Mataix J, Desco MC, Garcia-Pous M, Palacios E.
    Retina; 2009 Jan; 29(1):13-9. PubMed ID: 18854782
    [Abstract] [Full Text] [Related]

  • 14. Prognostic factors of vitreous hemorrhage secondary to exudative age-related macular degeneration.
    Hasegawa T, Otani A, Sasahara M, Gotoh N, Ooto S, Tamura H, Yamashiro K, Tsujikawa A, Yoshimura N.
    Am J Ophthalmol; 2010 Feb; 149(2):322-329.e1. PubMed ID: 20103057
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of injection frequency and visual acuity outcomes for ranibizumab monotherapy in exudative age-related macular degeneration.
    Dadgostar H, Ventura AA, Chung JY, Sharma S, Kaiser PK.
    Ophthalmology; 2009 Sep; 116(9):1740-7. PubMed ID: 19643484
    [Abstract] [Full Text] [Related]

  • 16. Intravitreal bevacizumab combined with photodynamic therapy for the treatment of occult choroidal neovascularization associated with serous pigment epithelium detachment in age-related macular degeneration.
    Ladas ID, Kotsolis AI, Papakostas TD, Rouvas AA, Karagiannis DA, Vergados I.
    Retina; 2007 Sep; 27(7):891-6. PubMed ID: 17891013
    [Abstract] [Full Text] [Related]

  • 17. A prospective study of visual function and quality of life following PDT in patients with wet age related macular degeneration.
    Armbrecht AM, Aspinall PA, Dhillon B.
    Br J Ophthalmol; 2004 Oct; 88(10):1270-3. PubMed ID: 15377549
    [Abstract] [Full Text] [Related]

  • 18. Photodynamic therapy with intravitreal application of triamcinolone acetonide in age-related macular degeneration: functional results in 54 patients.
    Frimpong-Boateng A, Bunse A, Rüfer F, Roider J.
    Acta Ophthalmol; 2009 Mar; 87(2):183-7. PubMed ID: 18547278
    [Abstract] [Full Text] [Related]

  • 19. Full macular translocation following photodynamic therapy in neovascular age-related macular degeneration.
    Suesskind D, Voelker M, Bartz-Schmidt KU, Gelisken F.
    Eye (Lond); 2008 Jun; 22(6):834-7. PubMed ID: 17401325
    [Abstract] [Full Text] [Related]

  • 20. Two-year visual outcomes after photodynamic therapy in age-related macular degeneration patients with or without polypoidal choroidal vasculopathy lesions.
    Tsuchiya D, Yamamoto T, Kawasaki R, Yamashita H.
    Retina; 2009 Jun; 29(7):960-5. PubMed ID: 19491727
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.